Select Medical Corporation
SEM | NYSE
$16.51
$0.00 (0.00%)
Nov 2, 2026, 10:32 AM ET · Market open
Market Data
Market Cap $2.05B
Enterprise Value $5.01B
Beta 0.79
Average Volume 2.28M
Shares Outstanding (Diluted) 123.51M
Shares Change YoY -2.14%
Institutional Ownership 72.26%
Exchange NYSE
ISIN US81619Q1058
Price Performance
Price Change 1M N/A
Price Change 3M 0.0%
Price Change 6M 0.7%
Price Change YTD 11.4%
Price Change 1Y 15.9%
Price Change 3Y 32.3%
Price Change 5Y -8.4%
1M CAGR (ann.) 0.1%
1Y CAGR (ann.) 10.1%
5Y CAGR (ann.) -4.3%
All-Time CAGR 8.8%
Valuation
PE Ratio 15.15
Forward PE 12.57
PEG Ratio -0.79
Forward PEG -20.39
PS Ratio 0.37
Forward PS 0.30
PB Ratio 1.17
P/FCF Ratio 17.45
P/Adj. FCF Ratio 19.48
P/OCF Ratio 5.88
EV/Sales 0.91
EV/EBIT 13.36
EV/EBITDA 9.67
EV/FCF 42.74
Earnings Yield 6.6%
FCF Yield 5.7%
Adj. FCF Yield 5.1%
Financial Health
Net Debt $1.85B
Total Debt $2.99B
Cash & Short-Term Investments $25.68M
Total Assets $6.04B
Current Ratio 1.15
Quick Ratio 1.15
Debt / Equity Ratio 1.70
Debt / EBITDA 5.77
Debt / FCF 25.51
OCF / Debt 0.12
Interest Coverage 2.76
Altman Z-Score 1.66
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 10.7%
Operating Profit Margin 5.8%
EBITDA Margin 9.4%
Net Profit Margin 2.4%
FCF Margin 2.1%
Adj. FCF Margin 1.9%
SBC / Revenue 0.2%
SBC Impact (per share) -10.4%
Returns
Return on Assets 2.2%
Return on Equity 7.8%
Return on Invested Capital 4.8%
Return on Capital Employed 6.3%
Return on Tangible Assets 3.8%
Historical Growth (CAGR)
Revenue CAGR 3Y -4.8%
Revenue CAGR 5Y -0.5%
Revenue CAGR 10Y 3.2%
EPS CAGR 3Y -12.0%
EPS CAGR 5Y -14.4%
EPS CAGR 10Y -0.5%
FCF CAGR 3Y -2.8%
FCF CAGR 5Y -35.8%
FCF CAGR 10Y 3.8%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 14
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Jul 30, 2026
EPS Estimate (next Q) $0.29
EPS Growth Est (next Q) -9.4%
Revenue Est (next Q) $1.4B
Revenue Growth Est (next Q) 4.3%
Fair Value Estimates
Graham Number $20.45
Graham Upside 23.9%
Lynch Fair Value $5.45
Lynch Upside -67.0%
Price Target $16.50
Price Target Upside -0.1%
Cash Flow
Operating Cash Flow $346.47M
Free Cash Flow $117.24M
Adj. Free Cash Flow $105.06M
FCF Per Share $0.95
OCF Per Share $2.81
OCF/S Ratio 6.3%
Income Statement
Revenue $5.52B
Gross Profit $588M
Operating Income $321.84M
EBITDA $518.25M
Net Income $133.53M
EPS (Diluted) $1.09
Revenue / Employee $121.88K
Profit / Employee $2.95K
Employees 45,300
Dividends
Annual Dividend $0.25
Dividend Yield 1.51%
Payout Ratio 22.9%
FCF Payout Ratio 26.8%
Adj. FCF Payout Ratio 29.9%
Dividend Growth (YoY) -3.7%
Pay Frequency Quarterly
Ex-Dividend Date May 14, 2026
Add to Watchlist
Select watchlists to add or remove SEM